Edesa Biotech, Inc. (EDSA)

NASDAQ

$2.80

$-0.09

(-3.19%)

Regular Market

Edesa Biotech, Inc. (EDSA) Live Price Chart

Last updated: ⁦2026-10-21 19:22:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Edesa Biotech, Inc. (EDSA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.80, with a market capitalization of $26.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.72 to $20.32. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$26.80M
Open	$3.02
Day's High	$133.70
Day's Low	$0.72
Previous Close	$2.82
Volume	33.86K
Average Volume	62.48K
P/E Ratio	--
52-Week High	$20.32
52-Week Low	$0.72
Dividend Yield	--
Earnings Date	--

Edesa Biotech, Inc. (EDSA) Stock Price Today

Edesa Biotech, Inc. (EDSA) is currently trading at $2.80 as of 2026-10-21 19:21:00, down 0.89% ($0.02) from the previous close of $2.82

During today's regular trading session, EDSA has traded between $0.72 and $133.70, with a trading volume of 33.86K shares. The current price is near the lower end of today's range.

Edesa Biotech, Inc. (EDSA) 7-Day Stock Price Change

Over the past seven days, Edesa Biotech, Inc. (EDSA) moved from $2.94 to $2.80, representing a decline of 4.93% ($0.15).

The stock traded between $2.52 and $3.56 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 59.43 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

EDSA 52-Week Price Position

Position in Range: 10.6%

52W Low$0.72

52W High$20.32

EDSA is currently trading at $2.80, placing it 10.6% of the way from its 52-week low of $0.72 to its 52-week high of $20.32. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Edesa Biotech, Inc. (EDSA)?

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Edesa Biotech, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	17
Exchange	NASDAQ
Company Website	https://www.edesabiotech.com

How to Buy Edesa Biotech, Inc. (EDSA) Stock on MEXC

Eligible investors can buy real shares of Edesa Biotech, Inc. (EDSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EDSA and Place Your Order

Open the RealStocks trading page and search for EDSA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Edesa Biotech, Inc. (EDSA) stock price today?

Edesa Biotech, Inc. (EDSA) is currently trading at $ 2.80, down 0.89% ($0.02) from the previous close of $ 2.82. Intraday prices update in real time during regular trading hours.

2.Is EDSA stock going up or down today?

As of 2026-10-21 19:21:00, EDSA is trading at $ 2.80, down 0.89% ($0.02) from its previous close of $ 2.82. The stock has traded between $ 0.72 and $ 133.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is EDSA pre-market price?

As of 2026-10-21 19:21:00, EDSA is trading at $ 2.94 in pre-market trading, up 4.08% ($0.12) from the previous close of $ 2.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EDSA after-hours price?

As of 2026-10-21 19:21:00, EDSA is trading at $ 3.01 in after-hours trading, up 6.88% ($0.19) from the regular-session close of $ 2.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EDSA stock trading now?

EDSA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EDSA sit relative to its 52-week high and low?

Over the past 52 weeks, EDSA has traded between a low of $ 0.72 and a high of $ 20.32. At $ 2.80, the stock is positioned 10.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Edesa Biotech, Inc. in?

Edesa Biotech, Inc. (EDSA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Edesa Biotech, Inc.'s market capitalization and where is it listed?

Edesa Biotech, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 26.80M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EDSA valued in terms of P/E ratio and EPS?

EDSA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Edesa Biotech, Inc. pay a dividend?

Edesa Biotech, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.